Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Aug 15, 2019
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notice of Changes to Funding Opportunities
- Notice of Extension of the Response Date for NOT-AT-19-030 "Request for Information (RFI): Important Considerations for Potential Creation of an Open-Access Repository or Database for Physiological and Anatomical Ontology of Acupoints"
National Center for Complementary and Integrative Health - Notice of Correction to Award Budget for RFA-DA-19-019 " HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R43/R44 - Clinical Trial Optional)"
National Institute on Drug Abuse - Notice of Correction to Award Budget for RFA-DA-19-020 " HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R41/R42 - Clinical Trial Optional)"
National Institute on Drug Abuse - Notice of Clarification for Suggested Tables for PAR-19-218 Undergraduate Research Initiative for Student Enhancement (RISE) (T34)
National Institute of General Medical Sciences - Notice of Clarification for Suggested Tables for PAR-19-219 "Maximizing Access to Research Careers (T34)"
National Institute of General Medical Sciences - Notice to Extend the Expiration Date of PAR-18-227, "Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)"
National Institute of Mental Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
National Institute on Drug Abuse - Notice of NINR Withdrawal from Participation in PAR-19-333 "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Not Allowed"
National Institute of Nursing Research - Notice of NINR Withdrawal from Participation in PAR-19-334 "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed"
National Institute of Nursing Research - Notice of NINR Withdrawal from Participation in PAR-19-335 "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Required"
National Institute of Nursing Research - Notice of Change to Key Dates for PAS-19-210 "Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed)"
National Institute of Neurological Disorders and Stroke
National Institute on Aging - New Expiration Date for PAR-OH-14-246 NIOSH Support for Conferences and Scientific Meetings (R13)
National Institute for Occupational Safety and Health - New Expiration Date for PAR-14-229 NIOSH Support for Conferences and Scientific Meetings (U13)
National Institute for Occupational Safety and Health - Notice of Change to Funding Opportunity in PAR-19-244 "International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)"
John E. Fogarty International Center
Notices of Intent to Publish
- Notice of Intent to Publish an NHLBI Funding Opportunity Announcement for STIMULATE-2 (R61/R33 Clinical Trial Required)
National Heart, Lung, and Blood Institute
Notices of Special Interest
- Notice of Special Interest for Small Business Research for Methods Development in Natural Products Chemistry
National Center for Complementary and Integrative Health
National Center for Advancing Translational Sciences
- Notice of Special Interest: NCI's Research Interests to Improve Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment
National Cancer Institute
Funding Opportunities
- Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
National Heart, Lung, and Blood Institute
- Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
- Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
National Heart, Lung, and Blood Institute
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Not Allowed
National Institute on Aging
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed
National Institute on Aging
National Center for Advancing Translational Sciences
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Required
National Institute on Aging
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
- Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program (U54 Clinical Trial Optional)
National Center for Advancing Translational Sciences
- Limited Competition: Renewals of, and Revisions and Resubmissions to, the Longitudinal Early-onset Alzheimers Disease Study (LEADS) Cooperative Agreement (U01 Clinical Trial Not Allowed)
National Institute on Aging
- The Biological Mechanisms of Metformin Effects on Aging and Longevity (R01 Clinical Trial Not Allowed)
National Institute on Aging
- Technologies to Advance Precision Medicine Diagnosis and Treatment of Infertility, Reproductive Tract and Gynecologic Disorders Affecting Fertility (R43/R44 Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Circadian Patterns of Gene Expression Associated with Disease (R01 - Clinical Trial Optional)
National Heart, Lung, and Blood Institute
National Institute on Drug Abuse
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Lynn Hudachek at lynn-hudachek @uiowa.edu